Hemorrhoidal Embolization Trial-1 (HEMBO-1)
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:
• Grade II or III hemorrhoidal disease as determined by a board-certified colorectal surgeon.
• Persistent or recurrent symptoms following hygiene and dietary measures or medication.
• Bleeding predominant ± pain symptoms.
• Undergoing planned rectal artery embolization (RAE) per standard clinical care.
• Male or female with age greater than 18 years, with the capacity and willingness to provide a written informed consent.
• Negative pregnancy test (if applicable).
Locations
United States
Minnesota
Mayo Clinic Minnesota
RECRUITING
Rochester
Contact Information
Primary
Desirae Howe-Clayton
Howe.Desirae@mayo.edu
507-255-0111
Time Frame
Start Date: 2024-06-07
Estimated Completion Date: 2026-12
Participants
Target number of participants: 20
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic
Collaborators: Terumo Corporation